Testing how the body responds to endotoxin
Part of Cancer, Heart & circulation, Hormones & metabolism, Immune system & allergy, Lungs & breathing clinical trials.
This study checks how your immune system (your body’s defense system) reacts to a controlled substance that triggers inflammation. It may help researchers understand why some people have stronger or weaker inflammatory responses.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years or older
- Be able to read, understand, and sign consent forms
- Be willing and able to come to the study center (CRU)
- Fast after midnight the night before your appointment
- Be generally healthy and able to do normal activities
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study tests anti-inflammatory lipid mediators in people with asthma. You may be eligible if your asthma is not well controlled despite regular inhaler use and you meet the specific lung function and health criteria.
This study looks at how the body's immune cells respond to damaged proteins in people with lung diseases. Researchers will take a small blood sample to study these immune responses, which could lead to better treatments.
This study tests how the nose reacts to a substance that causes mild inflammation in people with asthma. It may help understand airway inflammation and asthma better.
This study measures how immune cells respond when exposed to test “stimuli.” It needs healthy, nonpregnant adults and screens for certain infections and recent illnesses or medicines to help ensure the results aren’t affected by outside factors.
This study tests how three different anti-inflammatory drugs (dexamethasone, tocilizumab, and anakinra) affect the body's immune response during a controlled, short-term inflammation. It is for healthy young men who can safely receive an experimental substance that temporarily mimics an infection.
This study tests how your lungs’ immune cells respond after a controlled exposure to endotoxin. It may help researchers understand and prevent harmful lung inflammation, even though it is a short, research-focused intervention.
Hear when a new Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.